Assessment of Web-based education resources informing patients about stroke prevention in atrial fibrillation

Journal of Clinical Pharmacy and Therapeutics

Volumn 41, Issue 6, 2016, Pages 667-676

  Pandya, E ^a   Bajorek, B V ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

antithrombotics; assessment; atrial fibrillation; education resource; online; patient education; shared decision making; stroke; thromboprophylaxis; Web based

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; APIXABAN; CLOPIDOGREL; DABIGATRAN; DIPYRIDAMOLE; EDOXABAN; FLUINDIONE; PHENINDIONE; RIVAROXABAN; TICLOPIDINE; TRIFLUSAL; FIBRINOLYTIC AGENT; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; DECISION MAKING; DRUG EFFICACY; HUMAN; ONLINE SYSTEM; PATIENT CARE; PATIENT EDUCATION; PATIENT INFORMATION; PROPHYLAXIS; RISK BENEFIT ANALYSIS; STROKE PREVENTION; THROMBOSIS PREVENTION; COMPLICATION; HEMORRHAGE; INTERNET; RISK FACTOR; STROKE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; DABIGATRAN; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; INTERNET; PATIENT EDUCATION AS TOPIC; PYRAZOLES; PYRIDONES; RISK FACTORS; RIVAROXABAN; STROKE; WARFARIN;

EID: 84992448583     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12446     Document Type: Article

References (77)

1. January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: executive Summary: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol, 2014;64:2246–2280.
2. Quick reference guide: Atrial Fibrillation Information for the Health Practitioner 2014. 7/07/2015. Available at: http://www.healthnetworks.health.wa.gov.au/docs/QuickReferenceGuide_AtrialFibrillation.pdf. (accessed 24 August 2016).
3. Heidbuchel H, Verhamme P, Alings M et al. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J, 2013;34:2094–2106.
4. Holbrook AM, Pereira JA, Labiris R et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med, 2005;165:1095–1106.
5. Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med, 2009;361:1139–1151.
6. Patel MR, Mahaffey KW, Garg J et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med, 2011;365:883–891.
7. Granger CB, Alexander JH, McMurray JJ et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med, 2011;365:981–992.
8. Wang Y, Bajorek B. New Oral Anticoagulants in Practice: pharmacological and Practical Considerations. American Journal of Cardiovascular Drugs, 2014;143:175–189.
9. Witt DM, Delate T, Clark NP et al. Nonadherence with INR monitoring and anticoagulant complications. Thromb Res, 2013;132:e124–e130.
10. Orensky IA, Holdford DA. Predictors of noncompliance with warfarin therapy in an outpatient anticoagulation clinic. Pharmacotherapy, 2005;25:1801–1808.
11. Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: a case-control study. Am J Med, 1997;103:11–17.
12. Sjölander M, Eriksson M, Glader E-L. The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey. BMJ open, 2013;3:e003551.
13. Casais P, Meschengieser SS, Sanchez-Luceros A, Lazzari MA. Patients’ perceptions regarding oral anticoagulation therapy and its effect on quality of life. Curr Med Res Opin, 2005;21:1085–1090.
14. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence its importance in cardiovascular outcomes. Circulation, 2009;119:3028–3035.
15. January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol, 2014;64:e1–e76.
16. Campbell Cowan JC (Chair), Cheong V-L, Chung G et al. Atrial fibrillation: management. National Institute of Clinical Excellence, London, August 2014.
17. Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med, 2004;140:54–59.
18. Montori VM, Gafni A, Charles C. A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect, 2006;9:25–36.
19. Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns, 2006;60:301–312.
20. Coulter A, Entwistle V, Gilbert D. Sharing decisions with patients: is the information good enough? Br Med J, 1999;318:318.
21. All Party Parliamentary Groups on Global Health. Patient empowerment: for better quality, more sustainable health services globally. Available at: https://www.google.co.uk/webhp?sourceid=chrome-instant&ion=1&espv=2&ie=UTF-8#q=Patient+empowerment%3A+for+better+quality%2C+more+sustainable+health+services+globally (accessed 24 August 2016).
22. Seaburg L, Hess EP, Coylewright M, Ting HH, McLeod CJ, Montori VM. Shared Decision Making in Atrial Fibrillation Where We Are and Where We Should Be Going. Circulation, 2014;129:704–710.
23. Bajorek BV, Ogle SJ, Duguid MJ, Shenfield GM, Krass I. Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers. Med J Aust, 2007;186:175.
24. Finkelstein J, Cha E. Learning about Atrial Fibrillation using Social Media: A Qualitative Inquiry.
25. Alliance for Ageing Research-Alliance for Ageing ResearchAtrial Fibrillation Patient Survey: Online survey of AFib Patients 65+ Exploring Experiences with the Diagnosis and Treatment of AFib September 2012 [9/9/2015]. Available at: http://www.agingresearch.org/Publications/view/119#.VNuwrJ3F_Tp (accessed 24 August 2016).
26. Clarus Research Group. Insights and analysis- Highlights: Atrial Fibrillation Survey Report. January 2015.
27. Kumar N, Pandey A, Venkatraman A, Garg N. Are video sharing Web sites a useful source of information on hypertension? J Am Soc Hypertens, 2014;8:481–490.
28. Elwyn G, O'Connor A, Stacey D et al. International Patient Decision Aids Standards (IPDAS) collaboration. Developing a quality criteria framework for patient decision aid: online international Delphi consensus process. Br Med J, 2006;333:417–419.
29. Heikkinen K, Suomi R, Jääskeläinen M, Kaljonen A, Leino-Kilpi H, Salanterä S. The creation and evaluation of an ambulatory orthopedic surgical patient education web site to support empowerment. Computers Informatics Nursing, 2010;28:282–290.
30. Nguyen HQ, Donesky D, Reinke LF et al. Internet-based dyspnea self-management support for patients with chronic obstructive pulmonary disease. J Pain Symptom Manage, 2013;46:43–55.
31. Lee CJ, Gray SW, Lewis N. Internet use leads cancer patients to be active health care consumers. Patient Educ Couns, 2010;81:S63–S69.
32. Wann LS, Curtis AB, Ellenbogen KA et al. 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)A Report of the American College of Cardiology Foundation Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2011;57:1330–1337.
33. Jolley J. Introducing research and evidence-based practice for nursing and healthcare professionals. New York: Routledge, 2013.
34. Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol, 2013;13:117.
35. Johnson RB, Onwuegbuzie AJ, Turner LA. Toward a definition of mixed methods research. J Mix Method Res, 2007;1:112–133.
36. Patton MQ. Qualitative interviewing. In: Deborah Laughton C, ed. Qualitative research and evaluation methods, vol 3. Thousand Oaks: Sage. 71–72, 2002.
37. Creswell JW. Research design: Qualitative, quantitative, and mixed methods approaches. London, UK: Sage publications, 2013.
38. Downe-Wamboldt B. Content analysis: method, applications, and issues. Health Care Women Int, 1992;13:313–321.
39. Kondracki NL, Wellman NS, Amundson DR. Content analysis: review of methods and their applications in nutrition education. J Nutr Educ Behav, 2002;34:224–230.
40. Klaus K. Content analysis: An introduction to its methodology. London, UK: Sage Publications, 1980.
41. Skanes AC, Healey JS, Cairns JA et al. Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: recommendations for Stroke Prevention and Rate/Rhythm Control. Can J Cardiol, 2012; 28: 125–136.
42. Evidence Based Summary on Oral Anticoagulants and stroke prevention in Atrial fibrillation. NPS Mwdicinewise [Internet]. Available at: http://www.npsorg.au/medicines/heart-blood-and-blood-vessels/anti-clotting-medicines/for-health-professionals/evidence-summary/atrial-fibrillation (accessed 24 August 2016).
43. Preventing stroke in people with atrial fibrillation- NICE guidelines September 2015. May 2016. Available at: http://pathways.nice.org.uk/pathways/atrial-fibrillation#path=view%3A/pathways/atrial-fibrillation/preventing-stroke-in-people-with-atrial-fibrillation.xml&content=view-index (accessed 24 August 2016).
44. Hobbs FR, Taylor CJ, Geersing GJ, Rutten FH, Brouwer JR. European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care. Eur J Prev Cardiol, 2015;23:460–473.
45. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. CHEST J, 2010;137:263–272.
46. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey. CHEST J, 2010;138:1093–1100.
47. Mant J, Hobbs FDR, Fletcher K, Roalfe A, Fitzmaurice D, Lip GYH, Murray E. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. The Lancet 2007;370:493–503.
48. Abbott VP. Web page quality: can we measure it and what do we find? A report of exploratory findings. J Pub Health, 2000;22:191–197.
49. Steinberg PL, Wason S, Stern JM, Deters L, Kowal B, Seigne J. YouTube as Source of Prostate Cancer Information. Urology, 2010;75:619–622.
50. Md JP, Md EB. The Internet as a resource for palliative care and hospice: a review and proposals. J Pain Symptom Manage, 1998;16:59–68.
51. Samama MM, Guinet C. Laboratory assessment of new anticoagulants. Clin Chem Lab Med, 2011;49:761–772.
52. Wild D, Murray M, Donatti C. Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain. Expert Rev Pharmacoecon Outcomes Res, 2009;9:467–474.
53. Gebler-Hughes ES, Kemp L, Bond MJ. Patients’ perspectives regarding long-term warfarin therapy and the potential transition to new oral anticoagulant therapy. Ther Adv Drug Saf, 2014;5:220–228.
54. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. The Lancet 2006;367:404–411.
55. Choi JC, Dibonaventura MD, Kopenhafer L, Nelson WW. Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation. Patient Prefer Adherence, 2014;8:167–177.
56. Ghijben P, Lancsar E, Zavarsek S. Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best-Best Discrete Choice Experiment. Pharmacoeconomics, 2014;32:1115–1127.
57. Murray E, Lo B, Pollack L et al. The Impact of Health Information on the Internet on Health Care and the Physician-Patient Relationship: National U.S. Survey among 1.050 U.S. Physicians. J Med Internet Res, 2003;5:e17.
58. Eysenbach G. The impact of the Internet on cancer outcomes. CA Cancer J Clin, 2003;53:356–371.
59. Fuller R, Dudley N, Blacktop J. Avoidance hierarchies and preferences for anticoagulation–semi-qualitative analysis of older patients’ views about stroke prevention and the use of warfarin. Age Ageing, 2004;33:608–611.
60. Senoo K, Proietti M, Lane DA, Lip GY. Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin. Am J Med, 2015;129:600–607.
61. Chao T-F, Liu C-J, Tuan T-C et al. Comparisons of CHADS 2 and CHA 2 DS 2-VASc scores for stroke risk stratification in atrial fibrillation: which scoring system should be used for Asians? Heart Rhythm, 2016;13:46–53.
62. Fowler FJ Jr, Stilwell PDDL. Striving for Balance & Fairness. Boston: Informed Medical Decisions Foundation, 2011.
63. Trevena L, Barratt A. Integrated decision making: definitions for a new discipline. Patient Educ Couns, 2003;50:265–268.
64. Boyer C, Selby M, Scherrer J-R, Appel R. The health on the net code of conduct for medical and health websites. Comput Biol Med, 1998;28:603–610.
65. Rees CE, Ford JE, Sheard CE. Evaluating the reliability of DISCERN: a tool for assessing the quality of written patient information on treatment choices. Patient Educ Couns, 2002;47:273–275.
66. Sillence E, Briggs P, Harris PR, Fishwick L. How do patients evaluate and make use of online health information? Soc Sci Med, 2007;64:1853–1862.
67. Nasser S, Mullan J, Bajorek B. Assessing the quality, suitability and readability of internet-based health information about warfarin for patients. Australas Med J, 2012;5:194–203.
68. Schaefer C. How to develop patient versions of guidelines Communication. Guidelines International Network Conference-Amsterdam. p. 52–59.
69. How to produce an information brochure for patients and users of the healthcare system June 2008. Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-10/how_to_produce_an_information_brochure_-_methodology_guide.pdf (accessed 24 August 2016)
70. Chatzimarkakis J. Why patients should be more empowered: a European perspective on lessons learned in the management of diabetes. J Diabetes Sci Technol, 2010;4:1570–1573.
71. Anderson RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC. Patient empowerment: results of a randomized controlled trial. Diabetes Care, 1995;18:943–949.
72. Detmer DE, Singleton PD, MacLeod A, Wait S, Taylor M, Ridgwell J. The informed patient: study report: Citeseer; 2003.
73. The Royal Australian College of General Practitioners. Standards for general practices (4th edition) including Interpretive guide for Aboriginal and Torres Strait Islander health services: Informed patient decisions. Available from: http://www.racgp.org.au/your-practice/standards/standards4thedition/practice-services/1-2/informed-patient-decisions/ (accessed 24 August 2016).
74. Kagansky N, Knobler H, Rimon E, Ozer Z, Levy S. Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med, 2004;164:2044–2050.
75. Terryn B. Measuring literacy in developing countries from an international perspective. Montreal: UNESCO Institute for Statistics. 2003;1:2–4.
76. Nadar S, Begum N, Kaur B, Sandhu S, Lip GYH. Patients’ understanding of anticoagulant therapy in a multiethnic population. J R Soc Med, 2003;96:175–179.
77. Lip GY, Kamath S, Jafri M, Mohammed A, Bareford D. Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy the West Birmingham atrial fibrillation project. Stroke, 2002;33:238–242.